对药物不服药的氧化血水平的解释:一个药理动力学研究
Stephen Balevic1,2,3, Kai Sun3, Jennifer L Rogers3
1Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA stephen.balevic@duke.edu.
Lupus science & medicine
|April 30, 2024
概括
错过剂量时,氧化 (HCQ) 的血水平显著下降,80%的错过剂量导致60%的患者的低水平. 提出了一个算法来解释HCQ水平和估计遗漏剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 药物监测 药物监测 药物监测
背景情况:
- 氧化 (HCQ) 是广泛的处方,但坚持显著影响其治疗疗效.
- 由于药理动力学变异性,仅通过血液水平来监测患者对HCQ剂量方案的坚持是具有挑战性的.
- 了解错过剂量和HCQ血度之间的关系对于优化患者的治疗结果至关重要.
研究的目的:
- 描述氧化 (HCQ) 血水平与遗漏剂量频率之间的关系.
- 开发一种用于解释HCQ血液水平的算法,考虑剂量,时间和患者特异性药理动力学 (PK).
- 评估遗漏剂量对HCQ血度的影响,并确定最佳监测策略.
主要方法:
- 发表的HCQ药理动力学 (PK) 模型的外部验证.
- 虚拟患者群体 (1000名患者) 的发展,具有不同的体重和PK变异性.
- 在稳定状态下使用蒙特卡洛方法进行24万次HCQ血度模拟.
- 模拟随机删除剂量的比例的影响,以评估不粘附效应.
主要成果:
- 对于每天服用400毫克HCQ的患者,<0.1%的模拟血<200 ng/mL,完全遵守.
- 由于80%的剂量遗漏,大约60%的模拟HCQ度低于200ng/ng/mL.
- 在错过剂量的2-4天后,平均HCQ水平下降到200ng/mL以下,高峰和低谷之间的平均水平下降了29.9%.
结论:
- 提出了一种新的算法来解释HCQ血液水平和估计错过的剂量,考虑到PK变异性.
- 没有一个单一的HCQ血液水平切断值证明了所有程度的不坚持都具有足够的灵敏度和特异性.
- 未来的研究应该专注于测量低谷HCQ度,以更好地确定非坚持和有效性的目标水平.
相关概念视频
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
60
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
60
Drug Concentrations: Measurements
364
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
364
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
131
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
131
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Nonlinear Pharmacokinetics: Overview
358
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
358


